Macquarie Group
BCLI

Macquarie Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Macquarie Group’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-296
Closed -$21K – 2358
2020
Q1 		$21K Buy
+296
New +$21K ﹤0.01% 1911